Prosecution Insights
Last updated: November 04, 2026

Edge Biosystems Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Edge Biosystems Inc. manages a company patent portfolio in the Biotechnology & Pharmaceuticals technology area with 1 pending office action. This prosecution activity involves 1 distinct examiner and 1 distinct art unit, reflecting a centralized approach to its current patent applications. For practitioners, this means the entirety of the company's active USPTO engagement is focused on a single technical review process.

The busiest examiner for this portfolio is VANN-OJUEKAIYE, KENDRA RAYCHELL, who is currently overseeing 1 busiest examiner pending action. Since the total number of pending office actions is 1, this examiner is responsible for all of the company's active matters. The prosecution strategy for this Biotechnology & Pharmaceuticals portfolio is therefore uniquely dependent on the specific feedback and requirements of this one examiner.

The presence of 1 distinct art unit and 1 distinct examiner indicates that the company is not currently navigating multiple simultaneous examination tracks. While this limits the complexity of managing 1 pending office action, it also focuses the risk on a single point of review. The relationship between the examiner and the pending workload ensures that all current efforts are directed toward resolving this single matter.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
VANN-OJUEKAIYE, KENDRA RAYCHELL 1 0.0% +0.0%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17796558 METHOD FOR QUANTITATING NUCLEIC ACID LIBRARY VANN-OJUEKAIYE, KENDRA RAYCHELL —

Top Art Units

Art UnitApps
1682 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17796558 METHOD FOR QUANTITATING NUCLEIC ACID LIBRARY VANN-OJUEKAIYE, KENDRA RAYCHELL 1682 §103 Final Rejection — Pending Jul 29, 2022

Managing Edge Biosystems Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Edge Biosystems Inc. have?

Edge Biosystems Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Edge Biosystems Inc. applications?

Kendra Raychell Vann-Ojuekaiye has the most, with 1 of Edge Biosystems Inc.'s pending office actions.

What technology area are Edge Biosystems Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month